Global Human Albumin Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 108

Published Date: 28 Apr 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Human Albumin Injection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Human albumin solutions are used in a range of medical and surgical problems.

This report is a detailed and comprehensive analysis for global Human Albumin Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Human Albumin Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Albumin Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Albumin Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Albumin Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Albumin Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Albumin Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Octapharma, CSL Behring, Biotest (UK) Ltd, Baxter and Kedrion Biopharma, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Human Albumin Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Blood Extraction
    Recombine

Market segment by Application
    Hospital
    Clinic

Major players covered
    Octapharma
    CSL Behring
    Biotest (UK) Ltd
    Baxter
    Kedrion Biopharma, Inc.
    Grifols
    GE HealthCare
    Bio Products Laboratory
    Green Cross
    SK Plasma
    Instituto Grifols
    Takeda
    Hualan Bio
    Nanyue Biopharmaceuticals

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Albumin Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Albumin Injection, with price, sales, revenue and global market share of Human Albumin Injection from 2018 to 2023.
Chapter 3, the Human Albumin Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Albumin Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Albumin Injection market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Albumin Injection.
Chapter 14 and 15, to describe Human Albumin Injection sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Human Albumin Injection
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Human Albumin Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Blood Extraction
        1.3.3 Recombine
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Human Albumin Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital
        1.4.3 Clinic
    1.5 Global Human Albumin Injection Market Size & Forecast
        1.5.1 Global Human Albumin Injection Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Human Albumin Injection Sales Quantity (2018-2029)
        1.5.3 Global Human Albumin Injection Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Octapharma
        2.1.1 Octapharma Details
        2.1.2 Octapharma Major Business
        2.1.3 Octapharma Human Albumin Injection Product and Services
        2.1.4 Octapharma Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Octapharma Recent Developments/Updates
    2.2 CSL Behring
        2.2.1 CSL Behring Details
        2.2.2 CSL Behring Major Business
        2.2.3 CSL Behring Human Albumin Injection Product and Services
        2.2.4 CSL Behring Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 CSL Behring Recent Developments/Updates
    2.3 Biotest (UK) Ltd
        2.3.1 Biotest (UK) Ltd Details
        2.3.2 Biotest (UK) Ltd Major Business
        2.3.3 Biotest (UK) Ltd Human Albumin Injection Product and Services
        2.3.4 Biotest (UK) Ltd Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Biotest (UK) Ltd Recent Developments/Updates
    2.4 Baxter
        2.4.1 Baxter Details
        2.4.2 Baxter Major Business
        2.4.3 Baxter Human Albumin Injection Product and Services
        2.4.4 Baxter Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Baxter Recent Developments/Updates
    2.5 Kedrion Biopharma, Inc.
        2.5.1 Kedrion Biopharma, Inc. Details
        2.5.2 Kedrion Biopharma, Inc. Major Business
        2.5.3 Kedrion Biopharma, Inc. Human Albumin Injection Product and Services
        2.5.4 Kedrion Biopharma, Inc. Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Kedrion Biopharma, Inc. Recent Developments/Updates
    2.6 Grifols
        2.6.1 Grifols Details
        2.6.2 Grifols Major Business
        2.6.3 Grifols Human Albumin Injection Product and Services
        2.6.4 Grifols Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Grifols Recent Developments/Updates
    2.7 GE HealthCare
        2.7.1 GE HealthCare Details
        2.7.2 GE HealthCare Major Business
        2.7.3 GE HealthCare Human Albumin Injection Product and Services
        2.7.4 GE HealthCare Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 GE HealthCare Recent Developments/Updates
    2.8 Bio Products Laboratory
        2.8.1 Bio Products Laboratory Details
        2.8.2 Bio Products Laboratory Major Business
        2.8.3 Bio Products Laboratory Human Albumin Injection Product and Services
        2.8.4 Bio Products Laboratory Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Bio Products Laboratory Recent Developments/Updates
    2.9 Green Cross
        2.9.1 Green Cross Details
        2.9.2 Green Cross Major Business
        2.9.3 Green Cross Human Albumin Injection Product and Services
        2.9.4 Green Cross Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Green Cross Recent Developments/Updates
    2.10 SK Plasma
        2.10.1 SK Plasma Details
        2.10.2 SK Plasma Major Business
        2.10.3 SK Plasma Human Albumin Injection Product and Services
        2.10.4 SK Plasma Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 SK Plasma Recent Developments/Updates
    2.11 Instituto Grifols
        2.11.1 Instituto Grifols Details
        2.11.2 Instituto Grifols Major Business
        2.11.3 Instituto Grifols Human Albumin Injection Product and Services
        2.11.4 Instituto Grifols Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Instituto Grifols Recent Developments/Updates
    2.12 Takeda
        2.12.1 Takeda Details
        2.12.2 Takeda Major Business
        2.12.3 Takeda Human Albumin Injection Product and Services
        2.12.4 Takeda Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Takeda Recent Developments/Updates
    2.13 Hualan Bio
        2.13.1 Hualan Bio Details
        2.13.2 Hualan Bio Major Business
        2.13.3 Hualan Bio Human Albumin Injection Product and Services
        2.13.4 Hualan Bio Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Hualan Bio Recent Developments/Updates
    2.14 Nanyue Biopharmaceuticals
        2.14.1 Nanyue Biopharmaceuticals Details
        2.14.2 Nanyue Biopharmaceuticals Major Business
        2.14.3 Nanyue Biopharmaceuticals Human Albumin Injection Product and Services
        2.14.4 Nanyue Biopharmaceuticals Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Nanyue Biopharmaceuticals Recent Developments/Updates

3 Competitive Environment: Human Albumin Injection by Manufacturer
    3.1 Global Human Albumin Injection Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Human Albumin Injection Revenue by Manufacturer (2018-2023)
    3.3 Global Human Albumin Injection Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Human Albumin Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Human Albumin Injection Manufacturer Market Share in 2022
        3.4.2 Top 6 Human Albumin Injection Manufacturer Market Share in 2022
    3.5 Human Albumin Injection Market: Overall Company Footprint Analysis
        3.5.1 Human Albumin Injection Market: Region Footprint
        3.5.2 Human Albumin Injection Market: Company Product Type Footprint
        3.5.3 Human Albumin Injection Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Human Albumin Injection Market Size by Region
        4.1.1 Global Human Albumin Injection Sales Quantity by Region (2018-2029)
        4.1.2 Global Human Albumin Injection Consumption Value by Region (2018-2029)
        4.1.3 Global Human Albumin Injection Average Price by Region (2018-2029)
    4.2 North America Human Albumin Injection Consumption Value (2018-2029)
    4.3 Europe Human Albumin Injection Consumption Value (2018-2029)
    4.4 Asia-Pacific Human Albumin Injection Consumption Value (2018-2029)
    4.5 South America Human Albumin Injection Consumption Value (2018-2029)
    4.6 Middle East and Africa Human Albumin Injection Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Human Albumin Injection Sales Quantity by Type (2018-2029)
    5.2 Global Human Albumin Injection Consumption Value by Type (2018-2029)
    5.3 Global Human Albumin Injection Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Human Albumin Injection Sales Quantity by Application (2018-2029)
    6.2 Global Human Albumin Injection Consumption Value by Application (2018-2029)
    6.3 Global Human Albumin Injection Average Price by Application (2018-2029)

7 North America
    7.1 North America Human Albumin Injection Sales Quantity by Type (2018-2029)
    7.2 North America Human Albumin Injection Sales Quantity by Application (2018-2029)
    7.3 North America Human Albumin Injection Market Size by Country
        7.3.1 North America Human Albumin Injection Sales Quantity by Country (2018-2029)
        7.3.2 North America Human Albumin Injection Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Human Albumin Injection Sales Quantity by Type (2018-2029)
    8.2 Europe Human Albumin Injection Sales Quantity by Application (2018-2029)
    8.3 Europe Human Albumin Injection Market Size by Country
        8.3.1 Europe Human Albumin Injection Sales Quantity by Country (2018-2029)
        8.3.2 Europe Human Albumin Injection Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Human Albumin Injection Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Human Albumin Injection Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Human Albumin Injection Market Size by Region
        9.3.1 Asia-Pacific Human Albumin Injection Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Human Albumin Injection Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Human Albumin Injection Sales Quantity by Type (2018-2029)
    10.2 South America Human Albumin Injection Sales Quantity by Application (2018-2029)
    10.3 South America Human Albumin Injection Market Size by Country
        10.3.1 South America Human Albumin Injection Sales Quantity by Country (2018-2029)
        10.3.2 South America Human Albumin Injection Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Human Albumin Injection Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Human Albumin Injection Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Human Albumin Injection Market Size by Country
        11.3.1 Middle East & Africa Human Albumin Injection Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Human Albumin Injection Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Human Albumin Injection Market Drivers
    12.2 Human Albumin Injection Market Restraints
    12.3 Human Albumin Injection Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Human Albumin Injection and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Human Albumin Injection
    13.3 Human Albumin Injection Production Process
    13.4 Human Albumin Injection Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Human Albumin Injection Typical Distributors
    14.3 Human Albumin Injection Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Human Albumin Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Human Albumin Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Octapharma Basic Information, Manufacturing Base and Competitors
    Table 4. Octapharma Major Business
    Table 5. Octapharma Human Albumin Injection Product and Services
    Table 6. Octapharma Human Albumin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Octapharma Recent Developments/Updates
    Table 8. CSL Behring Basic Information, Manufacturing Base and Competitors
    Table 9. CSL Behring Major Business
    Table 10. CSL Behring Human Albumin Injection Product and Services
    Table 11. CSL Behring Human Albumin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. CSL Behring Recent Developments/Updates
    Table 13. Biotest (UK) Ltd Basic Information, Manufacturing Base and Competitors
    Table 14. Biotest (UK) Ltd Major Business
    Table 15. Biotest (UK) Ltd Human Albumin Injection Product and Services
    Table 16. Biotest (UK) Ltd Human Albumin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Biotest (UK) Ltd Recent Developments/Updates
    Table 18. Baxter Basic Information, Manufacturing Base and Competitors
    Table 19. Baxter Major Business
    Table 20. Baxter Human Albumin Injection Product and Services
    Table 21. Baxter Human Albumin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Baxter Recent Developments/Updates
    Table 23. Kedrion Biopharma, Inc. Basic Information, Manufacturing Base and Competitors
    Table 24. Kedrion Biopharma, Inc. Major Business
    Table 25. Kedrion Biopharma, Inc. Human Albumin Injection Product and Services
    Table 26. Kedrion Biopharma, Inc. Human Albumin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Kedrion Biopharma, Inc. Recent Developments/Updates
    Table 28. Grifols Basic Information, Manufacturing Base and Competitors
    Table 29. Grifols Major Business
    Table 30. Grifols Human Albumin Injection Product and Services
    Table 31. Grifols Human Albumin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Grifols Recent Developments/Updates
    Table 33. GE HealthCare Basic Information, Manufacturing Base and Competitors
    Table 34. GE HealthCare Major Business
    Table 35. GE HealthCare Human Albumin Injection Product and Services
    Table 36. GE HealthCare Human Albumin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. GE HealthCare Recent Developments/Updates
    Table 38. Bio Products Laboratory Basic Information, Manufacturing Base and Competitors
    Table 39. Bio Products Laboratory Major Business
    Table 40. Bio Products Laboratory Human Albumin Injection Product and Services
    Table 41. Bio Products Laboratory Human Albumin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Bio Products Laboratory Recent Developments/Updates
    Table 43. Green Cross Basic Information, Manufacturing Base and Competitors
    Table 44. Green Cross Major Business
    Table 45. Green Cross Human Albumin Injection Product and Services
    Table 46. Green Cross Human Albumin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Green Cross Recent Developments/Updates
    Table 48. SK Plasma Basic Information, Manufacturing Base and Competitors
    Table 49. SK Plasma Major Business
    Table 50. SK Plasma Human Albumin Injection Product and Services
    Table 51. SK Plasma Human Albumin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. SK Plasma Recent Developments/Updates
    Table 53. Instituto Grifols Basic Information, Manufacturing Base and Competitors
    Table 54. Instituto Grifols Major Business
    Table 55. Instituto Grifols Human Albumin Injection Product and Services
    Table 56. Instituto Grifols Human Albumin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Instituto Grifols Recent Developments/Updates
    Table 58. Takeda Basic Information, Manufacturing Base and Competitors
    Table 59. Takeda Major Business
    Table 60. Takeda Human Albumin Injection Product and Services
    Table 61. Takeda Human Albumin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Takeda Recent Developments/Updates
    Table 63. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 64. Hualan Bio Major Business
    Table 65. Hualan Bio Human Albumin Injection Product and Services
    Table 66. Hualan Bio Human Albumin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. Hualan Bio Recent Developments/Updates
    Table 68. Nanyue Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 69. Nanyue Biopharmaceuticals Major Business
    Table 70. Nanyue Biopharmaceuticals Human Albumin Injection Product and Services
    Table 71. Nanyue Biopharmaceuticals Human Albumin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 72. Nanyue Biopharmaceuticals Recent Developments/Updates
    Table 73. Global Human Albumin Injection Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 74. Global Human Albumin Injection Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 75. Global Human Albumin Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 76. Market Position of Manufacturers in Human Albumin Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 77. Head Office and Human Albumin Injection Production Site of Key Manufacturer
    Table 78. Human Albumin Injection Market: Company Product Type Footprint
    Table 79. Human Albumin Injection Market: Company Product Application Footprint
    Table 80. Human Albumin Injection New Market Entrants and Barriers to Market Entry
    Table 81. Human Albumin Injection Mergers, Acquisition, Agreements, and Collaborations
    Table 82. Global Human Albumin Injection Sales Quantity by Region (2018-2023) & (K Units)
    Table 83. Global Human Albumin Injection Sales Quantity by Region (2024-2029) & (K Units)
    Table 84. Global Human Albumin Injection Consumption Value by Region (2018-2023) & (USD Million)
    Table 85. Global Human Albumin Injection Consumption Value by Region (2024-2029) & (USD Million)
    Table 86. Global Human Albumin Injection Average Price by Region (2018-2023) & (US$/Unit)
    Table 87. Global Human Albumin Injection Average Price by Region (2024-2029) & (US$/Unit)
    Table 88. Global Human Albumin Injection Sales Quantity by Type (2018-2023) & (K Units)
    Table 89. Global Human Albumin Injection Sales Quantity by Type (2024-2029) & (K Units)
    Table 90. Global Human Albumin Injection Consumption Value by Type (2018-2023) & (USD Million)
    Table 91. Global Human Albumin Injection Consumption Value by Type (2024-2029) & (USD Million)
    Table 92. Global Human Albumin Injection Average Price by Type (2018-2023) & (US$/Unit)
    Table 93. Global Human Albumin Injection Average Price by Type (2024-2029) & (US$/Unit)
    Table 94. Global Human Albumin Injection Sales Quantity by Application (2018-2023) & (K Units)
    Table 95. Global Human Albumin Injection Sales Quantity by Application (2024-2029) & (K Units)
    Table 96. Global Human Albumin Injection Consumption Value by Application (2018-2023) & (USD Million)
    Table 97. Global Human Albumin Injection Consumption Value by Application (2024-2029) & (USD Million)
    Table 98. Global Human Albumin Injection Average Price by Application (2018-2023) & (US$/Unit)
    Table 99. Global Human Albumin Injection Average Price by Application (2024-2029) & (US$/Unit)
    Table 100. North America Human Albumin Injection Sales Quantity by Type (2018-2023) & (K Units)
    Table 101. North America Human Albumin Injection Sales Quantity by Type (2024-2029) & (K Units)
    Table 102. North America Human Albumin Injection Sales Quantity by Application (2018-2023) & (K Units)
    Table 103. North America Human Albumin Injection Sales Quantity by Application (2024-2029) & (K Units)
    Table 104. North America Human Albumin Injection Sales Quantity by Country (2018-2023) & (K Units)
    Table 105. North America Human Albumin Injection Sales Quantity by Country (2024-2029) & (K Units)
    Table 106. North America Human Albumin Injection Consumption Value by Country (2018-2023) & (USD Million)
    Table 107. North America Human Albumin Injection Consumption Value by Country (2024-2029) & (USD Million)
    Table 108. Europe Human Albumin Injection Sales Quantity by Type (2018-2023) & (K Units)
    Table 109. Europe Human Albumin Injection Sales Quantity by Type (2024-2029) & (K Units)
    Table 110. Europe Human Albumin Injection Sales Quantity by Application (2018-2023) & (K Units)
    Table 111. Europe Human Albumin Injection Sales Quantity by Application (2024-2029) & (K Units)
    Table 112. Europe Human Albumin Injection Sales Quantity by Country (2018-2023) & (K Units)
    Table 113. Europe Human Albumin Injection Sales Quantity by Country (2024-2029) & (K Units)
    Table 114. Europe Human Albumin Injection Consumption Value by Country (2018-2023) & (USD Million)
    Table 115. Europe Human Albumin Injection Consumption Value by Country (2024-2029) & (USD Million)
    Table 116. Asia-Pacific Human Albumin Injection Sales Quantity by Type (2018-2023) & (K Units)
    Table 117. Asia-Pacific Human Albumin Injection Sales Quantity by Type (2024-2029) & (K Units)
    Table 118. Asia-Pacific Human Albumin Injection Sales Quantity by Application (2018-2023) & (K Units)
    Table 119. Asia-Pacific Human Albumin Injection Sales Quantity by Application (2024-2029) & (K Units)
    Table 120. Asia-Pacific Human Albumin Injection Sales Quantity by Region (2018-2023) & (K Units)
    Table 121. Asia-Pacific Human Albumin Injection Sales Quantity by Region (2024-2029) & (K Units)
    Table 122. Asia-Pacific Human Albumin Injection Consumption Value by Region (2018-2023) & (USD Million)
    Table 123. Asia-Pacific Human Albumin Injection Consumption Value by Region (2024-2029) & (USD Million)
    Table 124. South America Human Albumin Injection Sales Quantity by Type (2018-2023) & (K Units)
    Table 125. South America Human Albumin Injection Sales Quantity by Type (2024-2029) & (K Units)
    Table 126. South America Human Albumin Injection Sales Quantity by Application (2018-2023) & (K Units)
    Table 127. South America Human Albumin Injection Sales Quantity by Application (2024-2029) & (K Units)
    Table 128. South America Human Albumin Injection Sales Quantity by Country (2018-2023) & (K Units)
    Table 129. South America Human Albumin Injection Sales Quantity by Country (2024-2029) & (K Units)
    Table 130. South America Human Albumin Injection Consumption Value by Country (2018-2023) & (USD Million)
    Table 131. South America Human Albumin Injection Consumption Value by Country (2024-2029) & (USD Million)
    Table 132. Middle East & Africa Human Albumin Injection Sales Quantity by Type (2018-2023) & (K Units)
    Table 133. Middle East & Africa Human Albumin Injection Sales Quantity by Type (2024-2029) & (K Units)
    Table 134. Middle East & Africa Human Albumin Injection Sales Quantity by Application (2018-2023) & (K Units)
    Table 135. Middle East & Africa Human Albumin Injection Sales Quantity by Application (2024-2029) & (K Units)
    Table 136. Middle East & Africa Human Albumin Injection Sales Quantity by Region (2018-2023) & (K Units)
    Table 137. Middle East & Africa Human Albumin Injection Sales Quantity by Region (2024-2029) & (K Units)
    Table 138. Middle East & Africa Human Albumin Injection Consumption Value by Region (2018-2023) & (USD Million)
    Table 139. Middle East & Africa Human Albumin Injection Consumption Value by Region (2024-2029) & (USD Million)
    Table 140. Human Albumin Injection Raw Material
    Table 141. Key Manufacturers of Human Albumin Injection Raw Materials
    Table 142. Human Albumin Injection Typical Distributors
    Table 143. Human Albumin Injection Typical Customers
List of Figures
    Figure 1. Human Albumin Injection Picture
    Figure 2. Global Human Albumin Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Human Albumin Injection Consumption Value Market Share by Type in 2022
    Figure 4. Blood Extraction Examples
    Figure 5. Recombine Examples
    Figure 6. Global Human Albumin Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Human Albumin Injection Consumption Value Market Share by Application in 2022
    Figure 8. Hospital Examples
    Figure 9. Clinic Examples
    Figure 10. Global Human Albumin Injection Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 11. Global Human Albumin Injection Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 12. Global Human Albumin Injection Sales Quantity (2018-2029) & (K Units)
    Figure 13. Global Human Albumin Injection Average Price (2018-2029) & (US$/Unit)
    Figure 14. Global Human Albumin Injection Sales Quantity Market Share by Manufacturer in 2022
    Figure 15. Global Human Albumin Injection Consumption Value Market Share by Manufacturer in 2022
    Figure 16. Producer Shipments of Human Albumin Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 17. Top 3 Human Albumin Injection Manufacturer (Consumption Value) Market Share in 2022
    Figure 18. Top 6 Human Albumin Injection Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Global Human Albumin Injection Sales Quantity Market Share by Region (2018-2029)
    Figure 20. Global Human Albumin Injection Consumption Value Market Share by Region (2018-2029)
    Figure 21. North America Human Albumin Injection Consumption Value (2018-2029) & (USD Million)
    Figure 22. Europe Human Albumin Injection Consumption Value (2018-2029) & (USD Million)
    Figure 23. Asia-Pacific Human Albumin Injection Consumption Value (2018-2029) & (USD Million)
    Figure 24. South America Human Albumin Injection Consumption Value (2018-2029) & (USD Million)
    Figure 25. Middle East & Africa Human Albumin Injection Consumption Value (2018-2029) & (USD Million)
    Figure 26. Global Human Albumin Injection Sales Quantity Market Share by Type (2018-2029)
    Figure 27. Global Human Albumin Injection Consumption Value Market Share by Type (2018-2029)
    Figure 28. Global Human Albumin Injection Average Price by Type (2018-2029) & (US$/Unit)
    Figure 29. Global Human Albumin Injection Sales Quantity Market Share by Application (2018-2029)
    Figure 30. Global Human Albumin Injection Consumption Value Market Share by Application (2018-2029)
    Figure 31. Global Human Albumin Injection Average Price by Application (2018-2029) & (US$/Unit)
    Figure 32. North America Human Albumin Injection Sales Quantity Market Share by Type (2018-2029)
    Figure 33. North America Human Albumin Injection Sales Quantity Market Share by Application (2018-2029)
    Figure 34. North America Human Albumin Injection Sales Quantity Market Share by Country (2018-2029)
    Figure 35. North America Human Albumin Injection Consumption Value Market Share by Country (2018-2029)
    Figure 36. United States Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 37. Canada Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Mexico Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Europe Human Albumin Injection Sales Quantity Market Share by Type (2018-2029)
    Figure 40. Europe Human Albumin Injection Sales Quantity Market Share by Application (2018-2029)
    Figure 41. Europe Human Albumin Injection Sales Quantity Market Share by Country (2018-2029)
    Figure 42. Europe Human Albumin Injection Consumption Value Market Share by Country (2018-2029)
    Figure 43. Germany Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 44. France Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. United Kingdom Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. Russia Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Italy Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Asia-Pacific Human Albumin Injection Sales Quantity Market Share by Type (2018-2029)
    Figure 49. Asia-Pacific Human Albumin Injection Sales Quantity Market Share by Application (2018-2029)
    Figure 50. Asia-Pacific Human Albumin Injection Sales Quantity Market Share by Region (2018-2029)
    Figure 51. Asia-Pacific Human Albumin Injection Consumption Value Market Share by Region (2018-2029)
    Figure 52. China Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 53. Japan Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Korea Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. India Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Southeast Asia Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Australia Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. South America Human Albumin Injection Sales Quantity Market Share by Type (2018-2029)
    Figure 59. South America Human Albumin Injection Sales Quantity Market Share by Application (2018-2029)
    Figure 60. South America Human Albumin Injection Sales Quantity Market Share by Country (2018-2029)
    Figure 61. South America Human Albumin Injection Consumption Value Market Share by Country (2018-2029)
    Figure 62. Brazil Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 63. Argentina Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Middle East & Africa Human Albumin Injection Sales Quantity Market Share by Type (2018-2029)
    Figure 65. Middle East & Africa Human Albumin Injection Sales Quantity Market Share by Application (2018-2029)
    Figure 66. Middle East & Africa Human Albumin Injection Sales Quantity Market Share by Region (2018-2029)
    Figure 67. Middle East & Africa Human Albumin Injection Consumption Value Market Share by Region (2018-2029)
    Figure 68. Turkey Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 69. Egypt Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Saudi Arabia Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. South Africa Human Albumin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Human Albumin Injection Market Drivers
    Figure 73. Human Albumin Injection Market Restraints
    Figure 74. Human Albumin Injection Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Human Albumin Injection in 2022
    Figure 77. Manufacturing Process Analysis of Human Albumin Injection
    Figure 78. Human Albumin Injection Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Octapharma
CSL Behring
Biotest (UK) Ltd
Baxter
Kedrion Biopharma, Inc.
Grifols
GE HealthCare
Bio Products Laboratory
Green Cross
SK Plasma
Instituto Grifols
Takeda
Hualan Bio
Nanyue Biopharmaceuticals

Related Reports

Global Human Albumin Injection Supply, Demand and Key Producers, 2023-2029

Global Human Albumin Injection Supply, Demand and Key Producers, 2023-2029

date 28 Apr 2023

date Pharma & Healthcare

The global Human Albumin Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Human Albumin Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Human Albumin Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 21 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Human Albumin Injection market size was valued at USD 407.5 million in 2023 and is forecast to a readjusted size of USD 565.2 million by 2030 with a CAGR of 4.8% during review period.

Product Tags

Human Albumin Injection

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>